Table 2 Quality assessment of DAs (n = 20) according to the IPDASi v4 criteria

Information

1

DA describes health condition or problem for which index decision is required

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

17

2

DA explicitly states the decision that needs to be considered (index decision)

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

20

3

DA describes the options available for the index decision

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

16

4

DA describes the positive features (benefits/advantages) of each option

X

X

X

X

X

X

X

X

8

5

DA describes the negative features (harms, side effects, or disadvantages) of each option

X

X

X

X

X

X

X

X

X

X

10

Values

6

DA describes what it is like to experience the consequences of the options (physical, psychological, social)

X

X

X

X

X

X

X

X

X 

X

X

X

X

X

14

Information

7

DA shows the negative and positive features of options in equal detail (using similar fonts, sequence, and representation of statistical information)

X

X

X

X

X

X

X

X

8

Evidence

8

DA (or associated documentation) provides citations to the evidence selected

X

X

X

X

X

X

X

X

X

9

9

DA (or associated documentation) provides a production or a publication date

X

X

X

X

X

X

X

X

X

X

X

X

X

X

14

10

DA (or associated documentation) provides information about the update policy

X

X

X

X

X

X

X

X

X

X

10

11

DA provides information about the levels of uncertainty around event or outcome probabilities

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

19

Disclosure

12

DA (or associated documentation) provides information about the funding source used for development

X 

X

X

X

X

X

X 

X

X

X

10

Test

13

DA describes what the test is designed to measure

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

20

14

DA describes the next steps typically taken if the test detects the condition or problem

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

19

15

DA describes the next steps if the condition or problem is not detected

X

X

X

X

4

16

DA has information about the consequences of detecting the condition or disease that would never have occurred if screening had not been done (lead time bias)

X

X

2

13

11

10

9

6

10

10

6

10

11

8

14

13

13

15

12

7

7

6

9